2026

2026年の実績

Outcomes of Patients With Hepatocellular Carcinoma Treated With Durvalumab Plus Tremelimumab in Real-World Clinical Practice Who Met or Did Not Meet the Inclusion Criteria for the Phase 3 HIMALAYA Trial.: Tomomitsu Matono, Toshifumi Tada, Atsushi Hiraoka, Masashi Hirooka, Yoshiko Nakamura, Osamu Yoshida, Kazuya Kariyama, Kazuhiro Nouso, Joji Tani, Asahiro Morishita, Masanori Atsukawa, Norio Itokawa, Tomomi Okubo, Taeang Arai, Koichi Takaguchi, Akemi Tsutsui, Takuya Nagano, Ei Itobayashi, Takashi Nishimura, Shinya Fukunishi, Hirayuki Enomoto, Kunihiko Tsuji, Kazunari Tanaka, Toru Ishikawa, Kazuto Tajiri, Hironori Tanaka, Hidenori Toyoda, Yuichi Koshiyama, Chikara Ogawa, Takeshi Hatanaka, Yuki Kanayama, Satoru Kakizaki, Kazuhito Kawata, Hidenao Noritake, Atsushi Naganuma, Hisashi Kosaka, Kosuke Matsui, Masaki Kaibori, Hidekatsu Kuroda, Yutaka Yata, Hiroki Nishikawa, Michitaka Imai, Tomoko Aoki, Hironori Ochi, Hideyuki Tamai, Jumpei Okamura, Shohei Komatsu, Takanori Matsuura, Shinichiro Nakamura, Yoshihide Ueda, Soo Ki Kim, Hideko Ohama, Fujimasa Tada, Takumi Fukumoto, Yoichi Hiasa, Masatoshi Kudo, Takashi Kumada.; Journal of Gastroenterology and Hepatology (in press)

Optimizing bevacizumab exposure in atezolizumab-based therapy for unresectable hepatocellular carcinoma: A nationwide real-world study: Kaho Aoe, Toshifumi Tada, Atsushi Hiraoka, Tomomitsu Matono, Masashi Hirooka, Kazuya Kariyama, Joji Tani, Masanori Atsukawa, Koichi Takaguchi, Ei Itobayashi, Takashi Nishimura, Kunihiko Tsuji, Toru Ishikawa, Kazuto Tajiri, Hironori Tanaka, Hidenori Toyoda, Chikara Ogawa, Takeshi Hatanaka, Satoru Kakizaki, Kazuhito Kawata, Naganuma Atsushi, Hisashi Kosaka, Hidekatsu Kuroda, Yutaka Yata, Hiroki Nishikawa, Michitaka Imai, Tomoko Aoki, Hironori Ochi, Hideyuki Tamai, Shohei Komatsu, Takanori Matsuura, Yoshihide Ueda, Soo Ki Kim, Hideko Ohama, Fujimasa Tada, Shinichiro Nakamura, Yoshiko Nakamura, Osamu Yoshida, Kazuhiro Nouso, Asahiro Morishita, Norio Itokawa, Tomomi Okubo, Taeang Arai, Akemi Tsutsui, Takuya Nagano, Shinya Fukunishi, Kazunari Tanaka, Yuichi Koshiyama, Yuki Kanayama, Hidenao Noritake, Hirayuki Enomoto, Kosuke Matsui, Masaki Kaibori, Jumpei Okamura, Takumi Fukumoto, Yoichi Hiasa, Masatoshi Kudo, Takashi Kumada; RELPEC Group and HCC 48 Group.; HEPATOLOGY. 2026 (in press)

Lymphocyte-Monocyte Ratio Predicts the Survival in Patients With HCC Treated With Durvalumab Plus Tremelimumab: Tomomitsu Matono, Toshifumi Tada, Atsushi Hiraoka, Masashi Hirooka, Kazuya Kariyama, Joji Tani, Masanori Atsukawa, Koichi Takaguchi, Ei Itobayashi, Takashi Nishimura, Kunihiko Tsuji, Toru Ishikawa, Kazuto Tajiri, Hironori Tanaka, Hidenori Toyoda, Chikara Ogawa, Takeshi Hatanaka, Satoru Kakizaki, Kazuhito Kawata, Atsushi Naganuma, Hisashi Kosaka, Hidekatsu Kuroda, Yutaka Yata, Hiroki Nishikawa, Michitaka Imai, Tomoko Aoki, Hironori Ochi, Hideyuki Tamai, Shohei Komatsu, Takanori Matsuura, Yoshihide Ueda, Soo Ki Kim, Hideko Ohama, Fujimasa Tada, Shinichiro Nakamura, Yoshiko Nakamura, Osamu Yoshida, Kazuhiro Nouso, Asahiro Morishita, Norio Itokawa, Tomomi Okubo, Taeang Arai, Akemi Tsutsui, Takuya Nagano, Shinya Fukunishi, Kazunari Tanaka, Yuichi Koshiyama, Yuki Kanayama, Hidenao Noritake, Hirayuki Enomoto, Kosuke Matsui, Masaki Kaibori, Jumpei Okamura, Takumi Fukumoto, Yoichi Hiasa, Masatoshi Kudo, Takashi Kumada; RELPEC Group and HCC 48 Group.; Liver International 2026; 46 (4): e70570.

Metabolic Dysfunction-Associated Steatotic Liver Disease and Sarcopenia:Review of Literature: Hiroki Nishikawa, Soo Ki Kim, Sachiyo Yoshio, Akira Asai.; Journal of Clinical Medicine 2026; 15 (4): 1661.

Liver transplantation in Acute-on-chronic liver failure (ACLF): Soo Ryang Kim, Soo Ki Kim, Toyokazu Okuda, Hiroki Nishikawa.; Hepatol Res. 2026; 56 (2): 148-160.

Primary Hepatic Squamous Cell Carcinoma: Soo Ryang Kim, Soo Ki Kim, Hisato Kobayashi, Toyokazu Okuda, Yumi Fujii, Makiho Sakamoto, Yu-ichiro Koma, Osamu Nakashima, Motoko Sasaki, Akira Asai, Hiroki Nishikawa.; Diagnostics (Basel). 2026; 16 (1): 120.

Efficacy of MR Imaging Findings in Clinical Management of Hepatic Encephalopathy and Alzheimer's Disease: Soo Ryang Kim, Soo Ki Kim, Hisato Kobayashi, Hiroki Nishikawa.; Hepatol Res. 2026; 56 (1): 11-20.

Lymphocyte-monocyte ratio predicts survival in patients with unresectable hepatocellular carcinoma treated with durvalumab plus tremelimumab: a multicenter analysis: Tatsuya Sakane, Toshifumi Tada, Hiroshi Tei, Saeko Kushida, Kenji Momose, Hirotaka Hirano, Chiharu Nishioka, Yosuke Yagi, Atsushi Yamamoto, Tomomitsu Matono, Ryutaro Yoshida, Yoshihide Ueda, Katsuhisa Nishi, Soo Ki Kim, Eiichiro Yasutomi, Sigeya Hirohata, Seitetsu Yoon, Mayumi Ehara, Miki Kawano, Shoji Tamura, Yuta Inoue, Jun Kitadai, Takanori Matsuura, Yuuki Shiomi, Yoshihiko Yano, Yuzo Kodama.; Hepatology Research. 2026; 56 (4): 527-537.

A Rare Case of Hepatic Echinococcus granulosus Infection Diagnosed by Autopsy in Japan: Akira Asai, Hisato Kawashima, Tomomi Hirota, Ryota Masutani, Shuichi Asano, Soo Ki Kim, Hiroki Nishikawa, Naomune Yamamoto.; Internal Medicine. 2026; 65 (9): 1199-1204.

「地域で支える心不全診療」循環器疾患における後方支援病院としての役割: ディスカッサント：佐々木健一; 「地域で支える心不全診療」講演会 2026/4/21

慢性肝疾患における骨折リスクの新たな視点：骨量・骨質・骨代謝マーカーの統合的解析: 金秀基; 第12回 KOBE Liver Conference 2026/3/14

〒653-0801　神戸市長田区房王寺町3-5-25

※「長田」とつく駅が、他にもあります。（JR新長田、高速長田）乗り間違いにご注意ください。

ＪＲ「兵庫駅」よりタクシーで約15分